Proteomics International Laboratories Limited
ASX:PIQ.AX
0.7 (AUD) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Proteomics International Laboratories Limited |
Symbool | PIQ.AX |
Munteenheid | AUD |
Prijs | 0.7 |
Beurswaarde | 91,702,099 |
Dividendpercentage | 0% |
52-weken bereik | 0.55 - 1.4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London) |
Website | https://www.proteomics.com.au |
An error occurred while fetching data.
Over Proteomics International Laboratories Limited
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)